Specialty CRO's Market

Specialty CRO's Market - Size, Share, Growth,
Outlook, and Opportunity Analysis, 2018-2026
Specialty clinical research organizations are distinct service providers in clinical research domain with
expertise based on different criteria. Earlier pharmaceutical and biotech firms, which are research
driven had conducted majority of the clinical research. However, since last two decades, most of the
clinical trial tasks such as lead discovery, preclinical studies, and different phases of clinical trials
have been slowly outsourced to external clinical research firms. These firms gained operational
expertise, geographic reach, and necessary infrastructure to efficiently conduct different clinical
research activities, in order to speed up the drug discovery process. This helps pharmaceutical and
biotech firms to launch novel therapies in the quickest possible time. Specialty clinical research
organizations goes one step ahead from conventional multitasking clinical research organization.
They gained proficiency in one or more niche segments amongst the large ecosystem of clinical
research industry, thereby offering improved quality of service to the sponsors.
Request Sample Copy of Research Report:
https://www.coherentmarketinsights.com/insight/request-sample/1627
Specialty CROs offers advantage over conventional CROs, as they are focused on specific area of
application based either on therapeutic area or specialty service they offer. Specialty CROs offer
solutions to the problems in clinical research such as increasing developmental cost, high rate of lead
candidate failure during clinical trial, and stringent regulatory demands such as clinical protocols
across the globe. Although it is still considered as an emerging model across the globe, it is gaining
significant traction in the Asian economies. Specialty CROs are playing a major role in mid-size or
small pharmaceutical and biotech firms, which are working in niche area and has unique clinical
research needs. Moreover, they offer cost effective and economical services as compared with large
CROs. Large CROs are increasingly focusing on approaching specialty CROs, as they find it difficult
to cater to unique problems.
Regional Insights
On the basis of geography, global specialty CROs market is segmented into North America, Latin
America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to dominate the
market over the forecast period, owing to the fact that pharmaceutical and biotech companies in
this region spends significant amount on research and development, in order to bring novel
therapies to the market. As per the estimation of Pharmaceutical Research and Manufacturers of
America (PhRMA) in 2017, on an average the pharmaceutical industry invested around US$ 0.8
billion to US$ 1.7 billion on research and development. According to the U.S. National Library for
Medicine, by January 2018, around 264,099 clinical studies were registered, which included all
the healthcare product spectrum. Asia Pacific is expected to provide lucrative opportunities for
market growth due to the cost effective services offered to the CROs in this region, large number
of skilled human resources, and availability of large patient pool.
Report includes chapters which deeply display the following deliverable about industry :
• Specialty CRO's Market Research Objective and Assumption
• Specialty CRO's Market Purview - Report Description, Executive Summary, and Coherent
Opportunity Map (COM)
• Specialty CRO's Market Dynamics, Regulations, and Trends Analysis - Market Dynamics,
Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals, Value
Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Specialty CRO's Market, By Regions
• Specialty CRO's Market Competition by Manufacturers including Production, Share, Revenue,
Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Specialty CRO's Market Manufacturers Profiles/Analysis including Company Basic Information,
Manufacturing Base and Its Competitors.
• Specialty CRO's Market Manufacturing Cost Analysis including Key Raw Materials and Key
Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market Positioning
and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Specialty CRO's Market Forecast including Production, Consumption, Import and Export Forecast
by Type, Applications and Region.
• Research Findings and Conclusion
Competitive Landscape
Some of key players operating in the specialty CROs market include Charles River
Laboratories, Profil Abiogenesis Clinpharm, Accell Clinical Research, Accelovance,
Aclires, Acquipharma, Cytespace Africa, DATATRAK International, Afraxis, David H
Murdock Research Institute, DaVita Clinical Research, Gateway Pharmacology
Laboratories, SAGE Labs, and Velesco Pharmaceutical Services.
Inquire Here Before Purchase:
https://www.coherentmarketinsights.com/insight/talk-to-analyst/1627
Market Taxonomy
On the basis of therapeutic area, the global specialty CROs market is segmented into:
•
•
•
•
Oncology
Cardiovascular Disease
Diabetes
Others
On the basis of service, the global specialty CROs market is segmented into:
•
•
•
•
•
Clinical Trial Management Service
Clinical Data Management Service
Pharmacovigilance Service
Regulatory Affairs/Medical Writing
Others
On the basis of region, the global specialty CROs market is segmented into:
•
•
•
•
•
•
North America
Latin America
Europe
Asia Pacific
Middle East
Africa
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-ready
syndicated research reports, custom market analysis, consulting services, and competitive analysis
through various recommendations related to emerging market trends, technologies, and potential
absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]

Download Report